229 related articles for article (PubMed ID: 25098478)
1. Sjögren syndrome and neuromyelitis optica spectrum disorder co-exist in a common autoimmune milieu.
Carvalho DC; Tironi TS; Freitas DS; Kleinpaul R; Talim NC; Lana-Peixoto MA
Arq Neuropsiquiatr; 2014 Aug; 72(8):619-24. PubMed ID: 25098478
[TBL] [Abstract][Full Text] [Related]
2. Neuromyelitis optica spectrum disorder as an initial presentation of primary Sjögren's syndrome.
Kahlenberg JM
Semin Arthritis Rheum; 2011 Feb; 40(4):343-8. PubMed ID: 20655576
[TBL] [Abstract][Full Text] [Related]
3. Presence of anti-Ro/SSA antibody may be associated with anti-aquaporin-4 antibody positivity in neuromyelitis optica spectrum disorder.
Park JH; Hwang J; Min JH; Kim BJ; Kang ES; Lee KH
J Neurol Sci; 2015 Jan; 348(1-2):132-5. PubMed ID: 25500159
[TBL] [Abstract][Full Text] [Related]
4. [Neuromyelitis optica spectrum disorders as initial presentation of Sjögren's syndrome: A case report].
Alva Díaz C; Andamayo Villalba L; Mori N; Ventura Chilón JJ; Romero R
Medwave; 2016 Feb; 16(1):e6388. PubMed ID: 26938585
[TBL] [Abstract][Full Text] [Related]
5. Neuromyelitis optica spectrum disorder and Sjögren syndrome are overlapping disorders and participate in the same autoimmunity context?
Pimentel ML
Arq Neuropsiquiatr; 2014 Aug; 72(8):577-9. PubMed ID: 25098472
[No Abstract] [Full Text] [Related]
6. Time-Dependent Analysis of Sicca Symptoms and Anti-Ro/SSA and Anti-La/SSB Antibodies in Patients with AQP4-IgG-Positive Neuromyelitis Optica Spectrum Disorder.
Akaishi T; Takahashi T; Misu T; Fujihara K; Nakashima I; Aoki M
Tohoku J Exp Med; 2023 Jul; 260(3):215-221. PubMed ID: 37081618
[TBL] [Abstract][Full Text] [Related]
7. Aquaporin-4-IgG positive neuromyelitis optica spectrum disorder and systemic autoimmune diseases overlap syndrome: a single-center experience.
Martín-Nares E; Hernandez-Molina G; Fragoso-Loyo H
Lupus; 2019 Oct; 28(11):1302-1311. PubMed ID: 31566079
[TBL] [Abstract][Full Text] [Related]
8. A case of pathology-proven neuromyelitis optica spectrum disorder with Sjögren syndrome manifesting aphasia and apraxia due to a localized cerebral white matter lesion.
Sawada J; Orimoto R; Misu T; Katayama T; Aizawa H; Asanome A; Takahashi K; Saito T; Anei R; Kamada K; Miyokawa N; Takahashi T; Fujihara K; Hasebe N
Mult Scler; 2014 Sep; 20(10):1413-6. PubMed ID: 24986696
[TBL] [Abstract][Full Text] [Related]
9. Neuromyelitis optica spectrum disorders associated with other autoimmune diseases.
Freitas E; Guimarães J
Rheumatol Int; 2015 Feb; 35(2):243-53. PubMed ID: 24952418
[TBL] [Abstract][Full Text] [Related]
10. Neuromyelitis optica spectrum disorder complicated with Sjogren syndrome successfully treated with tocilizumab: A case report.
Komai T; Shoda H; Yamaguchi K; Sakurai K; Shibuya M; Kubo K; Takahashi T; Fujio K; Yamamoto K
Mod Rheumatol; 2016; 26(2):294-6. PubMed ID: 24313919
[TBL] [Abstract][Full Text] [Related]
11. Recurrent optic neuritis in a patient with Sjogren syndrome and neuromyelitis optica spectrum disorder: A case report.
Zheng W; Liu X; Hou X; Zhu Y; Zhang T; Liao L
Medicine (Baltimore); 2020 Nov; 99(45):e23029. PubMed ID: 33157952
[TBL] [Abstract][Full Text] [Related]
12. Impact of comorbid Sjögren syndrome in anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders.
Akaishi T; Takahashi T; Fujihara K; Misu T; Fujimori J; Takai Y; Nishiyama S; Abe M; Ishii T; Aoki M; Nakashima I
J Neurol; 2021 May; 268(5):1938-1944. PubMed ID: 33416998
[TBL] [Abstract][Full Text] [Related]
13. [Differential diagnosis of neuromyelitis optica spectrum disorders].
Tanaka K; Tanaka M
Brain Nerve; 2010 Sep; 62(9):953-60. PubMed ID: 20844306
[TBL] [Abstract][Full Text] [Related]
14. Relationship Between Neuromyelitis Optica Spectrum Disorder and Sjögren's Syndrome: Central Nervous System Extraglandular Disease or Unrelated, Co-Occurring Autoimmunity?
Birnbaum J; Atri NM; Baer AN; Cimbro R; Montagne J; Casciola-Rosen L
Arthritis Care Res (Hoboken); 2017 Jul; 69(7):1069-1075. PubMed ID: 27696784
[TBL] [Abstract][Full Text] [Related]
15. The expanded spectrum of neuromyelitis optica: evidences for a new definition.
Lana-Peixoto MA; Callegaro D
Arq Neuropsiquiatr; 2012 Oct; 70(10):807-13. PubMed ID: 23060108
[TBL] [Abstract][Full Text] [Related]
16. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.
Bouzar M; Daoudi S; Hattab S; Bouzar AA; Deiva K; Wildemann B; Reindl M; Jarius S
J Neurol Sci; 2017 Oct; 381():240-244. PubMed ID: 28991690
[TBL] [Abstract][Full Text] [Related]
17. Neuromyelitis optica and non organ-specific autoimmunity.
Pittock SJ; Lennon VA; de Seze J; Vermersch P; Homburger HA; Wingerchuk DM; Lucchinetti CF; Zéphir H; Moder K; Weinshenker BG
Arch Neurol; 2008 Jan; 65(1):78-83. PubMed ID: 18195142
[TBL] [Abstract][Full Text] [Related]
18. Recurrent spinal cord attacks in a patient with a limited form of neuromyelitis optica.
Matsumoto H; Shimizu T; Okabe S; Konoma Y; Takahashi T; Hirakawa-Yamada M; Igeta Y; Hashida H
Intern Med; 2011; 50(5):509-13. PubMed ID: 21372469
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of anti-SSA/Ro antibody in Neuromyelitis optica spectrum disorders.
Lin L; Hang H; Zhang J; Lu J; Chen D; Shi J
Mult Scler Relat Disord; 2022 Feb; 58():103494. PubMed ID: 35051897
[TBL] [Abstract][Full Text] [Related]
20. Comparison of myelin oligodendrocyte glycoprotein (MOG)-antibody disease and AQP4-IgG-positive neuromyelitis optica spectrum disorder (NMOSD) when they co-exist with anti-NMDA (N-methyl-D-aspartate) receptor encephalitis.
Fan S; Xu Y; Ren H; Guan H; Feng F; Gao X; Ding D; Fang F; Shan G; Guan T; Zhang Y; Dai Y; Yao M; Peng B; Zhu Y; Cui L
Mult Scler Relat Disord; 2018 Feb; 20():144-152. PubMed ID: 29414288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]